321 related articles for article (PubMed ID: 27363440)
1. Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease.
Barnes PJ
Pharmacol Rev; 2016 Jul; 68(3):788-815. PubMed ID: 27363440
[TBL] [Abstract][Full Text] [Related]
2. Kinase inhibitors and airway inflammation.
Adcock IM; Chung KF; Caramori G; Ito K
Eur J Pharmacol; 2006 Mar; 533(1-3):118-32. PubMed ID: 16469308
[TBL] [Abstract][Full Text] [Related]
3. Kinase targets and inhibitors for the treatment of airway inflammatory diseases: the next generation of drugs for severe asthma and COPD?
Adcock IM; Caramori G
BioDrugs; 2004; 18(3):167-80. PubMed ID: 15161334
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes.
Barnes PJ
J Allergy Clin Immunol; 2015 Sep; 136(3):531-45. PubMed ID: 26343937
[TBL] [Abstract][Full Text] [Related]
5. Targeting 5-lipoxygenase-activating protein in asthma and chronic obstructive pulmonary disease.
Antoniu SA
Expert Opin Ther Targets; 2014 Nov; 18(11):1285-92. PubMed ID: 25213852
[TBL] [Abstract][Full Text] [Related]
6. Treatment of airway mucus hypersecretion.
Rogers DF; Barnes PJ
Ann Med; 2006; 38(2):116-25. PubMed ID: 16581697
[TBL] [Abstract][Full Text] [Related]
7. Novel drug targets for asthma and COPD: lessons learned from in vitro and in vivo models.
Baker KE; Bonvini SJ; Donovan C; Foong RE; Han B; Jha A; Shaifta Y; Smit M; Johnson JR; Moir LM
Pulm Pharmacol Ther; 2014 Dec; 29(2):181-98. PubMed ID: 24929072
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases.
Chopra P; Kanoje V; Semwal A; Ray A
Expert Opin Investig Drugs; 2008 Oct; 17(10):1411-25. PubMed ID: 18808304
[TBL] [Abstract][Full Text] [Related]
9. Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease.
Doukas J; Eide L; Stebbins K; Racanelli-Layton A; Dellamary L; Martin M; Dneprovskaia E; Noronha G; Soll R; Wrasidlo W; Acevedo LM; Cheresh DA
J Pharmacol Exp Ther; 2009 Mar; 328(3):758-65. PubMed ID: 19056934
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease.
Barnes PJ
J Allergy Clin Immunol; 2013 Mar; 131(3):636-45. PubMed ID: 23360759
[TBL] [Abstract][Full Text] [Related]
11. Tristetraprolin and its role in regulation of airway inflammation.
Prabhala P; Ammit AJ
Mol Pharmacol; 2015 Apr; 87(4):629-38. PubMed ID: 25429052
[TBL] [Abstract][Full Text] [Related]
12. Progress in the development of kinase inhibitors for treating asthma and COPD.
McClean N; Hasday JD; Shapiro P
Adv Pharmacol; 2023; 98():145-178. PubMed ID: 37524486
[TBL] [Abstract][Full Text] [Related]
13. Development of new drugs for COPD.
Barnes PJ
Curr Med Chem; 2013; 20(12):1531-40. PubMed ID: 22963554
[TBL] [Abstract][Full Text] [Related]
14. Role of p38 Mitogen-Activated Protein Kinase in Asthma and COPD: Pathogenic Aspects and Potential Targeted Therapies.
Pelaia C; Vatrella A; Gallelli L; Lombardo N; Sciacqua A; Savino R; Pelaia G
Drug Des Devel Ther; 2021; 15():1275-1284. PubMed ID: 33790539
[TBL] [Abstract][Full Text] [Related]
15. Agents against cytokine synthesis or receptors.
Yamagata T; Ichinose M
Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase inhibitors for the treatment of asthma and chronic obstructive pulmonary disease.
Page CP
Int Arch Allergy Immunol; 2014; 165(3):152-64. PubMed ID: 25532037
[TBL] [Abstract][Full Text] [Related]
17. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
Onoue S; Misaka S; Kawabata Y; Yamada S
Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
[TBL] [Abstract][Full Text] [Related]
18. Distinct PKA and Epac compartmentalization in airway function and plasticity.
Dekkers BG; Racké K; Schmidt M
Pharmacol Ther; 2013 Feb; 137(2):248-65. PubMed ID: 23089371
[TBL] [Abstract][Full Text] [Related]
19. Cytokine modulators as novel therapies for airway disease.
Barnes PJ
Eur Respir J Suppl; 2001 Dec; 34():67s-77s. PubMed ID: 12392037
[TBL] [Abstract][Full Text] [Related]
20. Identifying Molecular Targets for New Drug Development for Chronic Obstructive Pulmonary Disease: What Does the Future Hold?
Barnes PJ
Semin Respir Crit Care Med; 2015 Aug; 36(4):508-22. PubMed ID: 26238638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
